NeuroStar and Magstim both trace their roots to the early days of clinical TMS. NeuroStar came first to the US market and built its dominance through early insurance coverage wins and a large clinical trial program. Magstim’s Rapid² system has been a fixture in European research centers and maintains a strong international presence. Comparing them in the US market means looking at availability, insurance, and what your local clinic actually uses.
What You’ll Learn
- How the two systems differ technically
- Protocol capabilities on each platform
- US availability and insurance landscape
- Clinical outcomes for depression and OCD
Technical Platform Differences
NeuroStar uses a figure-8 coil design and a proprietary system platform built specifically for the US clinical market. Neuronetics has iterated the system over years, adding theta burst and accelerated protocol support. The system is designed for high-volume clinic use in the American context.
Magstim’s Rapid² system is a product of the UK-based Magstim company — the same company that built some of the earliest commercial TMS equipment. The Rapid² is a flexible platform known for its reliability and is widely used in research settings. It supports multiple coil configurations beyond figure-8, including double-cone coils for deeper stimulation.
Both systems deliver equivalent clinical protocols for the treatment of depression. The practical difference for most patients is what their local clinic uses, not a meaningful clinical distinction between the two platforms.
FDA Clearances
NeuroStar holds FDA clearances for:
- Major Depressive Disorder (treatment-resistant) — 2008 clearance
- Obsessive-Compulsive Disorder
- Smoking cessation
Magstim Rapid² holds FDA clearance for:
- Major Delective Disorder (treatment-resistant)
- OCD (via Magstim’s MagVenture partnership in some configurations)
Magstim’s FDA landscape is more complex. The core Rapid² platform has depression clearance. The company has partnerships and configurations that extend to other indications. Specific clearance status depends on the exact configuration and coils in use.
For OCD specifically, NeuroStar’s dedicated clearance is more straightforward from an insurance standpoint.
Protocols and Clinical Use
Both platforms support:
- Standard 10 Hz high-frequency left prefrontal stimulation
- Theta burst stimulation (iTBS) — 3-minute sessions
- Accelerated and intermittent protocols
NeuroStar has more published clinical data specifically using its system, largely because the US is its primary market and the trial program was extensive. Magstim’s data is distributed across research publications globally, partly because it’s been used more in academic research contexts.
For clinical practice, both are fully capable of delivering evidence-based protocols. The expertise of the treating psychiatrist matters more than which specific hardware sits in the treatment room.
US Availability and Insurance
NeuroStar has the dominant US market position. Finding a NeuroStar provider near you is relatively straightforward in most metropolitan areas. The insurance relationships are deep — most major insurers have specific policies and billing codes for NeuroStar TMS.
Magstim has a smaller US commercial footprint. It’s more commonly found in academic medical centers and research hospitals than in private practice TMS clinics. If you’re looking specifically for Magstim in the US, you may need to search more specifically.
Use our clinic finder to see what’s available in your area and filter by device type if the specific system matters to you.
The Bottom Line
For most US patients, NeuroStar is the more practical choice simply because it’s more widely available and has stronger insurance relationships. The clinical outcomes for depression are equivalent between the two systems.
Magstim is a strong option if you have access to a Magstim-equipped clinic and your insurance covers it. The research pedigree is real, and the system is proven. But in the US market, NeuroStar’s commercial infrastructure gives it a practical edge for most patients.
Search for TMS providers in your area or explore other device comparisons.
Key Takeaways
- NeuroStar is the most widely available TMS system in the US
- Magstim Rapid² has a strong research pedigree and global presence
- Both systems support equivalent clinical protocols for depression
- NeuroStar holds a specific OCD clearance; Magstim's OCD coverage is more complex
- Insurance coverage is more straightforward with NeuroStar in the US
Frequently Asked Questions
Is NeuroStar better than Magstim for TMS treatment?
Both systems are FDA-cleared for major depressive disorder and support equivalent clinical protocols. NeuroStar has better US market availability and insurance relationships. Magstim has a strong research pedigree. For most patients, the deciding factor is which system their clinic uses.
Does Magstim support theta burst stimulation?
Yes, the Magstim Rapid² supports theta burst stimulation (iTBS) and other accelerated protocols. The platform is fully capable of delivering evidence-based TMS treatment for depression.
Which system is more commonly used for OCD treatment?
NeuroStar has the more straightforward OCD indication in the US market. Its specific FDA clearance for OCD, combined with broader insurance acceptance, makes it the more practical choice for OCD patients in most regions.
Can I get TMS treatment with Magstim in the US?
Yes, but it's less common than NeuroStar. Magstim systems are found primarily in academic medical centers and research hospitals. Use our clinic finder to see if a Magstim-equipped provider is near you.
Find a TMS Clinic Near You
Browse verified TMS providers with device information, ratings, and insurance details.